日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Assessment of Access Barriers to Rifaximin Among Patients with Hepatic Encephalopathy Using Adjudicated Claims Data

利用已裁定的理赔数据评估肝性脑病患者获得利福昔明的障碍

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03145-3
Jesudian, Arun; Gagnon-Sanschagrin, Patrick; Maitland, Jessica; Yokoji, Kana; Guérin, Annie; Heimanson, Zeev; Samson, Aaron; Olujohungbe, Olamide; Bumpass, Brock
神经科学
发表日期：2025
文献求助 收藏

Real-World Trends and Future Projections of the Prevalence of Cirrhosis and Hepatic Encephalopathy Among Commercially and Medicare-Insured Adults in the United States

美国商业保险和联邦医疗保险参保成年人中肝硬化和肝性脑病患病率的真实世界趋势和未来预测

期刊:Clinical and Translational Gastroenterology
影响因子:3
doi:10.14309/ctg.0000000000000823
Wong, Robert J; Gagnon-Sanschagrin, Patrick; Heimanson, Zeev; Maitland, Jessica; Bellefleur, Remi; Guérin, Annie; Samson, Aaron; Olujohungbe, Olamide; Bumpass, Brock
肝硬化
神经科学
发表日期：2025
文献求助 收藏

Rifaximin plus lactulose versus lactulose alone for reducing the risk of HE recurrence

利福昔明联合乳果糖与单独使用乳果糖相比，在降低肝性脑病复发风险方面具有优势

期刊:Hepatology Communications
影响因子:4.6
doi:10.1097/HC9.0000000000000436
Sanyal, Arun J; Kowdley, Kris V; Reau, Nancy S; Pyrsopoulos, Nikolaos T; Allen, Christopher; Heimanson, Zeev; Bajaj, Jasmohan S
神经科学
发表日期：2024
文献求助 收藏

Treatment-Free Interval: A Novel Approach to Assessing Real-World Treatment Effectiveness and Economic Impact Among Patients with Irritable Bowel Syndrome with Diarrhea

无治疗间隔：一种评估腹泻型肠易激综合征患者真实世界治疗效果和经济影响的新方法

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-024-02832-x
Lacy, Brian E; Gagnon-Sanschagrin, Patrick; Heimanson, Zeev; Bungay, Rebecca; Bellefleur, Remi; Guérin, Annie; Bumpass, Brock; Borroto, Danellys; Joseph, George; Dashputre, Ankur A
肠易激综合征
发表日期：2024
文献求助 收藏

Plecanatide Improves Abdominal Bloating and Bowel Symptoms of Irritable Bowel Syndrome with Constipation

普卡那肽可改善便秘型肠易激综合征的腹胀和肠道症状

期刊:Digestive Diseases and Sciences
影响因子:2.5
doi:10.1007/s10620-024-08330-y
Brenner, Darren M; Sharma, Amol; Rao, Satish S C; Laitman, Adam P; Heimanson, Zeev; Allen, Christopher; Sayuk, Gregory S
肠易激综合征
发表日期：2024
文献求助 收藏

Abdominal Pain Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea

利福昔明对伴有腹泻的肠易激综合征患者腹痛的反应

期刊:Clinical and Translational Gastroenterology
影响因子:3
doi:10.14309/ctg.0000000000000144
Lembo, Anthony; Rao, Satish S C; Heimanson, Zeev; Pimentel, Mark
肠易激综合征
发表日期：2020
文献求助 收藏

Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea

乳果糖呼气试验预测利福昔明治疗腹泻型肠易激综合征患者的疗效

期刊:American Journal of Gastroenterology
影响因子:7.6
doi:10.14309/ajg.0000000000000444
Rezaie, Ali; Heimanson, Zeev; McCallum, Richard; Pimentel, Mark
肠易激综合征
发表日期：2019
文献求助 收藏